Search

Vibol Tan

Examiner (ID: 3478, Phone: (571)272-1811 , Office: P/2844 )

Most Active Art Unit
2819
Art Unit(s)
2819, 2844
Total Applications
2718
Issued Applications
2530
Pending Applications
32
Abandoned Applications
163

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4401552 [patent_doc_number] => 06171591 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-09 [patent_title] => 'Recombinant nodavirus compositions and methods' [patent_app_type] => 1 [patent_app_number] => 8/986659 [patent_app_country] => US [patent_app_date] => 1997-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12331 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/171/06171591.pdf [firstpage_image] =>[orig_patent_app_number] => 986659 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/986659
Recombinant nodavirus compositions and methods Dec 7, 1997 Issued
08/952694 IGG/IGM RATIO FOR DETERMINING EFFECTIVENESS OF INTERFERON THERAPY IN INDIVIDUALS WITH HCV INFECTIONS Dec 4, 1997 Abandoned
08/978291 HLA-RESTRICTED HEPATITIS B VIRUS CTL EPITOPES Nov 24, 1997 Abandoned
Array ( [id] => 4253688 [patent_doc_number] => 06203827 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-20 [patent_title] => 'Composition containing readily absorbable calcium and process for producing the same' [patent_app_type] => 1 [patent_app_number] => 8/952738 [patent_app_country] => US [patent_app_date] => 1997-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4065 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/203/06203827.pdf [firstpage_image] =>[orig_patent_app_number] => 952738 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/952738
Composition containing readily absorbable calcium and process for producing the same Nov 24, 1997 Issued
Array ( [id] => 1564980 [patent_doc_number] => 06376170 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-23 [patent_title] => 'Ligand capture-directed selection of antibody' [patent_app_type] => B1 [patent_app_number] => 08/972564 [patent_app_country] => US [patent_app_date] => 1997-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 11 [patent_no_of_words] => 16837 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/376/06376170.pdf [firstpage_image] =>[orig_patent_app_number] => 08972564 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/972564
Ligand capture-directed selection of antibody Nov 17, 1997 Issued
Array ( [id] => 3995019 [patent_doc_number] => 05922553 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-13 [patent_title] => 'Method of detecting protein by immuno RNA' [patent_app_type] => 1 [patent_app_number] => 8/972225 [patent_app_country] => US [patent_app_date] => 1997-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3605 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/922/05922553.pdf [firstpage_image] =>[orig_patent_app_number] => 972225 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/972225
Method of detecting protein by immuno RNA Nov 16, 1997 Issued
08/913080 METHOD FOR THE DIAGNOSIS OF INFECTIONS Nov 9, 1997 Abandoned
Array ( [id] => 4144294 [patent_doc_number] => 06063583 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-16 [patent_title] => 'Cyclic amp response element binding protein (CREB)-CREB binding protein complex' [patent_app_type] => 1 [patent_app_number] => 8/961739 [patent_app_country] => US [patent_app_date] => 1997-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16240 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/063/06063583.pdf [firstpage_image] =>[orig_patent_app_number] => 961739 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/961739
Cyclic amp response element binding protein (CREB)-CREB binding protein complex Oct 30, 1997 Issued
08/860847 METHODS FOR INHIBITING THE TRANSCRIPTION-ENHANCING ACTIVITY OF THE X PROTEIN OF HEPATITIS B VIRUS Oct 15, 1997 Abandoned
Array ( [id] => 3949201 [patent_doc_number] => 05998584 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-07 [patent_title] => 'Reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome' [patent_app_type] => 1 [patent_app_number] => 8/949017 [patent_app_country] => US [patent_app_date] => 1997-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15391 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/998/05998584.pdf [firstpage_image] =>[orig_patent_app_number] => 949017 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/949017
Reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome Oct 9, 1997 Issued
Array ( [id] => 1477793 [patent_doc_number] => 06451592 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-17 [patent_title] => 'Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis' [patent_app_type] => B1 [patent_app_number] => 08/944465 [patent_app_country] => US [patent_app_date] => 1997-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 63 [patent_figures_cnt] => 68 [patent_no_of_words] => 73701 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/451/06451592.pdf [firstpage_image] =>[orig_patent_app_number] => 08944465 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/944465
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis Oct 5, 1997 Issued
Array ( [id] => 4308495 [patent_doc_number] => 06316209 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'Methods for diabetes susceptibility assessment in asymptomatic patients' [patent_app_type] => 1 [patent_app_number] => 8/937955 [patent_app_country] => US [patent_app_date] => 1997-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5792 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/316/06316209.pdf [firstpage_image] =>[orig_patent_app_number] => 937955 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/937955
Methods for diabetes susceptibility assessment in asymptomatic patients Sep 24, 1997 Issued
08/914403 PEPTIDE LIBRARY AND SCREENING SYSTEMS Aug 18, 1997 Abandoned
Array ( [id] => 1535756 [patent_doc_number] => 06337180 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-08 [patent_title] => 'Peptide reagent enabling a primary Epstein-Barr virus infection to be detected by testing for the corresponding antibodies, and method for using this reagent' [patent_app_type] => B1 [patent_app_number] => 08/860089 [patent_app_country] => US [patent_app_date] => 1997-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3248 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/337/06337180.pdf [firstpage_image] =>[orig_patent_app_number] => 08860089 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/860089
Peptide reagent enabling a primary Epstein-Barr virus infection to be detected by testing for the corresponding antibodies, and method for using this reagent Aug 14, 1997 Issued
Array ( [id] => 1331202 [patent_doc_number] => 06596476 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-22 [patent_title] => 'Hepatitis C assay' [patent_app_type] => B1 [patent_app_number] => 08/905054 [patent_app_country] => US [patent_app_date] => 1997-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14739 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/596/06596476.pdf [firstpage_image] =>[orig_patent_app_number] => 08905054 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/905054
Hepatitis C assay Jul 31, 1997 Issued
Array ( [id] => 3994920 [patent_doc_number] => 05922545 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-13 [patent_title] => 'In vitro peptide and antibody display libraries' [patent_app_type] => 1 [patent_app_number] => 8/902623 [patent_app_country] => US [patent_app_date] => 1997-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 33292 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/922/05922545.pdf [firstpage_image] =>[orig_patent_app_number] => 902623 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/902623
In vitro peptide and antibody display libraries Jul 28, 1997 Issued
Array ( [id] => 1599715 [patent_doc_number] => 06475717 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-05 [patent_title] => 'Method for detecting and determining mediators' [patent_app_type] => B1 [patent_app_number] => 08/900576 [patent_app_country] => US [patent_app_date] => 1997-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7584 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/475/06475717.pdf [firstpage_image] =>[orig_patent_app_number] => 08900576 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/900576
Method for detecting and determining mediators Jul 24, 1997 Issued
Array ( [id] => 4264651 [patent_doc_number] => 06306579 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-23 [patent_title] => 'Recombinant antigen from the NS3 region of the hepatitis C virus' [patent_app_type] => 1 [patent_app_number] => 8/892704 [patent_app_country] => US [patent_app_date] => 1997-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6870 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/306/06306579.pdf [firstpage_image] =>[orig_patent_app_number] => 892704 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/892704
Recombinant antigen from the NS3 region of the hepatitis C virus Jul 14, 1997 Issued
Array ( [id] => 4125894 [patent_doc_number] => 06146614 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-14 [patent_title] => 'Method for determining lymphocyte distribution and trafficking in mammals using imaging' [patent_app_type] => 1 [patent_app_number] => 8/886578 [patent_app_country] => US [patent_app_date] => 1997-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7646 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/146/06146614.pdf [firstpage_image] =>[orig_patent_app_number] => 886578 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/886578
Method for determining lymphocyte distribution and trafficking in mammals using imaging Jun 30, 1997 Issued
Array ( [id] => 4296850 [patent_doc_number] => 06251407 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence' [patent_app_type] => 1 [patent_app_number] => 8/820943 [patent_app_country] => US [patent_app_date] => 1997-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5655 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 221 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/251/06251407.pdf [firstpage_image] =>[orig_patent_app_number] => 820943 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/820943
Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence Jun 5, 1997 Issued
Menu